99 / 112
97
WFSBP 2015
Industry Sessions
S
unday
, 14 J
une
2015
SA-01
Industry sponsored Symposium
16:00–17:30
Trianti Hall
Bipolar disorder as metabolic inflammatory disorder:
Implications for disease modeling and interventional
priorities
Chair: Joseph R. Calabrese, USA
SA-01-001
Bipolar disorder and metabolic disorder: Implications
of depressive symptoms for cognitive function
Roger S. McIntyre, Canada
SA-01-002
Gene expression changes in animal models of mood
disorders: The effect of pharmacological intervention
Marco Andrea Riva, Italy
supported by an educational grant from
Sumitomo Dainippon Pharma Co. Ltd.
M
onday
, 15 J
une
2015
SA-02
Industry sponsored Symposium
17:00–18:30
Trianti Hall
Orexin receptor antagonist and sleep disorder
Chair: Masatoshi Takeda, Japan
SA-02-001
Solving the mysteries of sleep and wakefulness:
from the discovery of orexin to forward genetics
Masashi Yanagisawa, Japan
supported by an educational grant from MSD K.K.
T
uesday
, 16 J
une
2015
SA-03
Industry sponsored Symposium
13:30–15:00
Skalkotas Hall
Managing behavioral emergencies
Chair: Konstantinos Fountoulakis, Greece
SA-03-001
Management of behavioral emergencies in Europe:
The French model
Pierre-Michel Llorca, France
SA-03-002
Experience with inhaled route of administration
in behavioral emergencies
Andreas Erfurth, Austria
supported by an educational grant from Ferrer
W
ednesday
, 17 J
une
2015
SA-04
Industry sponsored Symposium
13:30–15:00
Skalkotas Hall
Could it be Niemann-Pick disease Type C?
A differential diagnosis of organic psychoses
Chair: Hans-Hermann Klünemann, Germany
SA-04-001
Making the correct diagnosis:
How to recognise a rare disease
Hans-Hermann Klünemann, Germany
SA-04-002
Identifying disorders with organic psychoses:
Revolutionising differential diagnosis
Olivier Bonnot, France
SA-04-003
Novel approaches to screening, diagnosis
and disease management in NP-C
Mark Roberts, United Kingdom
supported by an educational grant from Actelion